Migraine is one of the most common neurological disorders, and for decades it has been debated whether migraine with aura (MwA) and migraine without aura (MwoA) are merely different manifestations of the same disease or whether they are two distinct entities. A recent narrative review in the Journal of Headache and Pain summarizes the available data on epidemiology, genetics, clinical characteristics, neuroimaging and treatment response. The result: there is increasing evidence that the two subtypes differ not only in terms of symptoms, but also in their biological basis. For neurologists, this raises the question of whether understanding these differences should also have diagnostic and therapeutic consequences in the future.
You May Also Like
- Gonarthrosis and coxarthrosis: update on conservative treatment
Pain relief, targeted movement and relief
- Idiopathic and progressive pulmonary fibrosis (IPF/PPF)
An instrument for clinical use
- Rosacea - multifaceted and multifactorial
Topical and systemic active ingredients: proven and new therapeutic approaches
- Lung cancer
Multidisciplinary teams in oncology
- From diagnostics to personalized therapy
Nuclear medical imaging for Parkinson’s disease
- Psoriasis in difficult localizations: Nail psoriasis
IL-23 and IL-17 as a target – selected study findings
- Artificial intelligence in diabetes prevention
Lifestyle interventions are better accepted with AI
- B-cell lymphomas